Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01833455 · ClinicalTrials.gov registry record · Phase 2
Premature Ventricular Contractions (PVCs) and Blood Pressure Control
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT01833455: Clinical Trial Phase 2 study, sponsored by University of Wisconsin, Madison.
NCT01833455 is a Phase 2 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 8 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01833455, a Phase 2 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if reduction in premature ventricular contraction (PVC) burden results in a decrease in blood pressure, sympathetic outflow, plasma catecholamines and an improvement in baroreflex gain. Flecainide will be used for PVC suppression in a randomized, double-blinded, crossover fashion.
Primary Outcome
Mean arterial blood pressure was calculated from non-invasive systolic and diastolic arm measurements.
Interventions
- DRUG PVC Suppression using Flecainide
- DRUG No PVC Suppression using Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
Why NCT01833455 stopped before completion
NCT01833455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which PVC Suppression using Flecainide is the first listed.
NCT01833455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01833455 about?
NCT01833455 is a clinical study titled "Premature Ventricular Contractions (PVCs) and Blood Pressure Control". The purpose of this study is to determine if reduction in premature ventricular contraction (PVC) burden results in a decrease in blood pressure, sympathetic outflow, plasma catecholamines and an improvement in baroreflex gain. Flecainide will be used for PVC suppression in a randomized, double-blin...
What is the current status of trial NCT01833455?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2013-02. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01833455?
The interventions under investigation include: PVC Suppression using Flecainide (DRUG), No PVC Suppression using Placebo (DRUG).
Who is sponsoring clinical trial NCT01833455?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01833455's enrollment target sits among peer trials
8 1990th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia